Keywords
COVID-19, acute myocardial infarction, type 2 diabetes, obesity, cardiovascular complications
How to Cite
Solomenchuk, T., Labinska, O., Halkevych, M., Khamuliak, K., & Gel, K. (2023). COVID-19 as a predictor of acute myocardial infarction in patients with type 2 diabetes and obesity (clinical case). The Practitioner, (4), 78-83. Retrieved from https://plr.com.ua/index.php/journal/article/view/781
Abstract
The article highlights a clinical case of an acute myocardial infarction in the patient with obesity after suffering from COVID-19 to improve the diagnosis of cardiovascular complications and choose the optimal method of prevention and treatment.
References
1. Hendren NS, Drazner MH, Bozkurt B, Cooper Jr LT. Description and proposed managemen of the acute COVID-19 cardiovascular syndrome. Circulation. 2020; 141:1903-14. doi: https://doi.org/10.1161/circulationaha.120.047349
2. Prodanchuk MG, Balan GM, Kurdil NV, Zhminko PG, Bubalo NM, Dyachuk DD, et al. Toxicologist`s opinion on the mechanisms of virus-induced hemoglobinopathies with toxic pneumonitis and systemic hypoxemia from COVID-19 and substantiation of rational detoxification methods. Ukrainian journal of modern problems of toxicology. 2020;1:23-41.
3. Casey K, Iteen A, Nicolini R, Auten J. COVID-19 pneumonia with hemoptysis: Acute segmental pulmonary emboli associated with novel coronavirus infection. Am J Emerg Med. 2020 Apr 8. pii: S0735-6757(20)30239-4. doi: 10.1016/j.ajem.2020.04.011.
4. Pons S., Fodil S., Azoulay E., Zafrani L. (2020) The vascular endothelium: The cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Critical Care, 24(353):1-8. doi.org/10.1186/s13054-020-03062-7.
5. Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science. 2020;368(6490):473-4.
6. Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med. 2008 Aug 28;359(9):938-49. doi: 10.1056/NEJMra0801082. PMID: 18753650.
7. Armstrong EJ, Waltenberger J, Rogers JH. Percutaneous Coronary Intervention in Patients With Diabetes: Current Concepts and Future Directions. Journal of Diabetes Science and Technology 2014;8(3):581-9.
8. Carrié D. The use of the Cre8 Stent in Patients With Diabetes Mellitus. Interv Cardiol. 2016 May;11(1):47-50.
9. Kukula K, Klopotowski M, Kunicki PK, Jamiolkowski J, Debski A, Bekta P, et al. Platelet aggregation and risk of stent thrombosis or bleeding in interventionally treated diabetic patients with acute coronary syndrome. BMC Cardiovascular Disorders. 2016;16(252):1-8.
10. Ritter A, Kreis NN, Louwen F, Yuan J. Obesity and COVID-19: Molecular Mechanisms Linking Both Pandemics. Int J Mol Sci. 2020;21(16):5793. Published 2020 Aug 12. doi:10.3390/ijms21165793
11. Korakas E, Ikonomidis I, Kousathana F, Balampanis K, Kountouri A, Raptis A, et. al. Obesity and COVID-19: immune and metabolic derangement as a possible link to adverse clinical outcomes. Am J Physiol Endocrinol Metab. 2020 Jul 1;319(1):E105-E109. doi: 10.1152/ajpendo.00198.2020. Epub 2020 May 27. PMID: 32459524; PMCID: PMC7322508.
12. Ahmed S, Zimba O, Gasparyan AY. Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad. Clin Rheumatol. 2020 Sep;39(9):2529-2543. doi: 10.1007/s10067-020-05275-1. Epub 2020 Jul 11. PMID: 32654082; PMCID: PMC7353835.
13. Корж АН. Поражение сердечно-сосудистой системы при COVID-19. Східноєвропейський журнал внутрішньої та сімейної медицини. 2021;1:10-6. doi: 10.15407/internalmed2021.01.010.
14. Gustafson D, Raju S, Wu R, Ching C, Veitch S, Rathnakumar K, et. al. Overcoming Barriers: The Endothelium As a Linchpin of Coronavirus Disease 2019 Pathogenesis? Arterioscler Thromb Vasc Biol. 2020 Aug;40(8):1818-1829. doi: 10.1161/ATVBAHA.120.314558. Epub 2020 Jun 8. PMID: 32510978; PMCID: PMC7370857.
15. Carfora V, Spiniello G, Ricciolino R, et al. Anticoagulant treatment in COVID-19: a narrative review. J Thromb Thrombolysis. 2021;51(3):642-648. doi:10.1007/s11239-020-02242-0
2. Prodanchuk MG, Balan GM, Kurdil NV, Zhminko PG, Bubalo NM, Dyachuk DD, et al. Toxicologist`s opinion on the mechanisms of virus-induced hemoglobinopathies with toxic pneumonitis and systemic hypoxemia from COVID-19 and substantiation of rational detoxification methods. Ukrainian journal of modern problems of toxicology. 2020;1:23-41.
3. Casey K, Iteen A, Nicolini R, Auten J. COVID-19 pneumonia with hemoptysis: Acute segmental pulmonary emboli associated with novel coronavirus infection. Am J Emerg Med. 2020 Apr 8. pii: S0735-6757(20)30239-4. doi: 10.1016/j.ajem.2020.04.011.
4. Pons S., Fodil S., Azoulay E., Zafrani L. (2020) The vascular endothelium: The cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Critical Care, 24(353):1-8. doi.org/10.1186/s13054-020-03062-7.
5. Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science. 2020;368(6490):473-4.
6. Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med. 2008 Aug 28;359(9):938-49. doi: 10.1056/NEJMra0801082. PMID: 18753650.
7. Armstrong EJ, Waltenberger J, Rogers JH. Percutaneous Coronary Intervention in Patients With Diabetes: Current Concepts and Future Directions. Journal of Diabetes Science and Technology 2014;8(3):581-9.
8. Carrié D. The use of the Cre8 Stent in Patients With Diabetes Mellitus. Interv Cardiol. 2016 May;11(1):47-50.
9. Kukula K, Klopotowski M, Kunicki PK, Jamiolkowski J, Debski A, Bekta P, et al. Platelet aggregation and risk of stent thrombosis or bleeding in interventionally treated diabetic patients with acute coronary syndrome. BMC Cardiovascular Disorders. 2016;16(252):1-8.
10. Ritter A, Kreis NN, Louwen F, Yuan J. Obesity and COVID-19: Molecular Mechanisms Linking Both Pandemics. Int J Mol Sci. 2020;21(16):5793. Published 2020 Aug 12. doi:10.3390/ijms21165793
11. Korakas E, Ikonomidis I, Kousathana F, Balampanis K, Kountouri A, Raptis A, et. al. Obesity and COVID-19: immune and metabolic derangement as a possible link to adverse clinical outcomes. Am J Physiol Endocrinol Metab. 2020 Jul 1;319(1):E105-E109. doi: 10.1152/ajpendo.00198.2020. Epub 2020 May 27. PMID: 32459524; PMCID: PMC7322508.
12. Ahmed S, Zimba O, Gasparyan AY. Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad. Clin Rheumatol. 2020 Sep;39(9):2529-2543. doi: 10.1007/s10067-020-05275-1. Epub 2020 Jul 11. PMID: 32654082; PMCID: PMC7353835.
13. Корж АН. Поражение сердечно-сосудистой системы при COVID-19. Східноєвропейський журнал внутрішньої та сімейної медицини. 2021;1:10-6. doi: 10.15407/internalmed2021.01.010.
14. Gustafson D, Raju S, Wu R, Ching C, Veitch S, Rathnakumar K, et. al. Overcoming Barriers: The Endothelium As a Linchpin of Coronavirus Disease 2019 Pathogenesis? Arterioscler Thromb Vasc Biol. 2020 Aug;40(8):1818-1829. doi: 10.1161/ATVBAHA.120.314558. Epub 2020 Jun 8. PMID: 32510978; PMCID: PMC7370857.
15. Carfora V, Spiniello G, Ricciolino R, et al. Anticoagulant treatment in COVID-19: a narrative review. J Thromb Thrombolysis. 2021;51(3):642-648. doi:10.1007/s11239-020-02242-0
Downloads
Download data is not yet available.